Home › Funds › PSP Research LLC › IMCR

PSP Research LLC position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

PSP Research LLC reported holding 7,000 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$212K, representing 0.15% of its reported portfolio and ranking #35 among its reported holdings. PSP Research LLC has disclosed IMCR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)7.00K sh
Reported value held$212.03K
Portfolio Weight0.15%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's IMCR position evolved

PSP Research LLC first disclosed a stake in IMCR in Q4 2025 at 14,424 shares (US$501K). Across 4 filings, PSP Research LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 7,000 shares valued at US$212K — a reduction of -8,141 shares quarter over quarter.. Notable position changes include a 54% trim in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 14.42K $500.66K New
Q1 2026 15.14K $456.50K Add
Q2 2026 15.14K $480.73K Hold
Q3 2026 7.00K $212.03K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 32 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has PSP Research LLC held IMCR?

PSP Research LLC has disclosed IMCR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in IMCR?

As of Q3 2026, PSP Research LLC holds 7.00K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $212.03K, representing 0.15% of its reported portfolio and ranking #35.

Has PSP Research LLC been buying or selling IMCR?

In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in IMCR.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.